|
DOPEY2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.576060E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.009170E-01 |
| Normal-vs-Stage2 |
3.840100E-02 |
| Normal-vs-Stage3 |
1.342810E-01 |
| Normal-vs-Stage4 |
8.838600E-01 |
| Stage1-vs-Stage2 |
2.475800E-01 |
| Stage1-vs-Stage3 |
4.475400E-01 |
| Stage1-vs-Stage4 |
6.590200E-01 |
| Stage2-vs-Stage3 |
7.109800E-01 |
| Stage2-vs-Stage4 |
2.095200E-01 |
| Stage3-vs-Stage4 |
4.268200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.037900E-02 |
| Normal-vs-AfricanAmerican |
2.712100E-02 |
| Normal-vs-Asian |
7.231600E-01 |
| Caucasian-vs-AfricanAmerican |
5.662200E-01 |
| Caucasian-vs-Asian |
7.021800E-01 |
| AfricanAmerican-vs-Asian |
5.376800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.618480E-02 |
| Normal-vs-Female |
2.160500E-03 |
| Male-vs-Female |
1.135560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.822400E-01 |
| Normal-vs-Extreme_Weight |
4.404600E-01 |
| Normal-vs-Obese |
4.837800E-03 |
| Normal-vs-Extreme_Obese |
3.214800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.315400E-01 |
| Normal_Weight-vs-Obese |
2.813900E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.669600E-01 |
| Extreme_Weight-vs-Obese |
2.283600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.536000E-01 |
| Obese-vs-Extreme_Obese |
7.321300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.299500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.008000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.231000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.767200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.083200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.866500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.059800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.004100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.224400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.944400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.555800E-02 |
| Normal-VS-Type2 PRCC |
1.207810E-01 |
| Normal-VS-KIRP CIMP |
4.624100E-02 |
| Normal-VS-Unclassified PRCC |
1.127670E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.501200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.566200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.904500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.819800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.584580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.875800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.783800E-01 |
| Normal-vs-N1 |
4.198400E-02 |
| Normal-vs-N2 |
3.507000E-01 |
| N0-vs-N1 |
3.699200E-01 |
| N0-vs-N2 |
5.916000E-01 |
| N1-vs-N2 |
8.855600E-01 |
|
|
